Andrew S. Allegretti, Xavier Vela Parada, Guillermo A. Ortiz, Joshua Long, Scott Krinsky, Sophia Zhao, Bryan C. Fuchs, Mozhdeh Sojoodi, Dongsheng Zhang, S. Ananth Karumanchi, Sahir Kalim, Sagar U. Nigwekar, Ravi I. Thadhani, Samir M. Parikh, Raymond T. Chung – 23 August 2018 – Acute kidney injury in decompensated cirrhosis has limited therapeutic options, and novel mechanistic targets are urgently needed. Angiopoietin‐2 is a context‐specific antagonist of Tie2, a receptor that signals vascular quiescence.

Marc G. Ghany, Timothy M. Block – 22 August 2018

Tatyana Kushner, Monika Sarkar – 22 August 2018

Bo Hyun Kim, W. Ray Kim – 22 August 2018

Brian J. McMahon – 22 August 2018

Norah A. Terrault, Anna S. F. Lok, Brian J. McMahon, Kyong‐Mi Chang, Jessica P. Hwang, Maureen M. Jonas, Robert S. Brown, Natalie H. Bzowej, John B. Wong – 22 August 2018

Norah A. Terrault, Anna S. F. Lok, Brian J. McMahon, Kyong‐Mi Chang, Jessica P. Hwang, Maureen M. Jonas, Robert S. Brown, Natalie H. Bzowej, John B. Wong – 22 August 2018

Kathy Jackson, Stephen Locarnini, Robert Gish – 22 August 2018

Joseph C. Ahn, Joseph Ahn – 22 August 2018

Ryan A. Hlady, Aishwarya Sathyanarayan, Joyce J. Thompson, Dan Zhou, Qunfeng Wu, Kien Pham, Jeong‐Heon Lee, Chen Liu, Keith D. Robertson – 22 August 2018 – Disruption of epigenetic mechanisms has been intimately linked to the etiology of human cancer. Understanding how these epigenetic mechanisms (including DNA methylation [5mC], hydroxymethylation [5hmC], and histone post‐translational modifications) work in concert to drive cancer initiation and progression remains unknown. Hepatocellular carcinoma (HCC) is increasing in frequency in Western countries but lacks efficacious treatments.